Interacting Drugs |
Dasatinib vs Ciprofloxacin (Systemic) |
Security Level |
 |
Mechanism |
Ciprofloxacin (Systemic): May enhance the QTc-prolonging effect of QTc-Prolonging Agents. |
Management |
Monitor therapy |
Dasatinib vs Ciprofloxacin (Systemic)
Post Review about Dasatinib vs Ciprofloxacin (Systemic) Click here to cancel reply.
Other Interactions of Dasatinib
Other Interactions of Ciprofloxacin (Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.